SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15642808
Source:
http://linkedlifedata.com/resource/pubmed/id/15642808
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0330095
,
umls-concept:C0532362
,
umls-concept:C1704638
,
umls-concept:C1883709
,
umls-concept:C2350017
pubmed:issue
1
pubmed:dateCreated
2005-1-11
pubmed:abstractText
To describe the clinical, perimetric, and electroretinographic (ERG) results of 4 patients with cone dysfunction following irofulven treatment including the histopathologic and immunocytochemical features of one patient's retinas.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating
,
http://linkedlifedata.com/resource/pubmed/chemical/Glial Fibrillary Acidic Protein
,
http://linkedlifedata.com/resource/pubmed/chemical/Rhodopsin
,
http://linkedlifedata.com/resource/pubmed/chemical/Sesquiterpenes
,
http://linkedlifedata.com/resource/pubmed/chemical/irofulven
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0003-9950
pubmed:author
pubmed-author:GuptaNishaN
,
pubmed-author:LeeMichael SMS
,
pubmed-author:LoewensteinJohnJ
,
pubmed-author:MilamAnn HAH
,
pubmed-author:PensonRichard TRT
,
pubmed-author:SeidenMichael VMV
,
pubmed-author:WepnerMeredith SMS
pubmed:issnType
Print
pubmed:volume
123
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
29-34
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15642808-Adult
,
pubmed-meshheading:15642808-Aged
,
pubmed-meshheading:15642808-Antineoplastic Agents, Alkylating
,
pubmed-meshheading:15642808-Electroretinography
,
pubmed-meshheading:15642808-Female
,
pubmed-meshheading:15642808-Fluorescent Antibody Technique, Indirect
,
pubmed-meshheading:15642808-Glial Fibrillary Acidic Protein
,
pubmed-meshheading:15642808-Humans
,
pubmed-meshheading:15642808-Middle Aged
,
pubmed-meshheading:15642808-Neoplasms
,
pubmed-meshheading:15642808-Retinal Cone Photoreceptor Cells
,
pubmed-meshheading:15642808-Retinal Diseases
,
pubmed-meshheading:15642808-Rhodopsin
,
pubmed-meshheading:15642808-Sesquiterpenes
,
pubmed-meshheading:15642808-Visual Field Tests
,
pubmed-meshheading:15642808-Visual Fields
pubmed:year
2005
pubmed:articleTitle
Cone damage in patients receiving high-dose irofulven treatment.
pubmed:affiliation
Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44124, USA. leem4@ccf.org
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Case Reports
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II